{"name":"Tallac Therapeutics","slug":"tallac-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPN202TUJ4Nm1xZ3AwUEFZbjh0cGl1NWc5WDJFLW03VHhlZnV0R28wOFR4UC0wNlJnSHV6WVY4aG9mdEtDZ1phbHdKWnUyaEhuTzUteERfdkpJdnA1S1VZVGp3TlpwcXhxeEJZeEttTzYwZlNKTHBtZ0dXVGhtSnZZeUs3bkxhTFpVZ2d0c3d5Mm83eGtlRmZJU3FseW5lYVhoeVBESV8zRW9fb1FPTk1jd1ZUb1dyeGlrTFBuMUhCcFBzTnI2azJadG9fWHlxVS1RX0Roc3NNbnIwS19aVEJXbE5zQUJBUHVwdDhhYlluVGZhcXlRVW1wak5xazJ2bFlNMmFzaV9oVENvOWRsTEJFdVRwc2Z3TURveTlIRkJRQXpLV3JWTldMRnBwZG1EdEJSVGdTVlhUVktvS3drSHFrTGFZUmhpcnpOUXl2cEN5OERFZVpE?oc=5","date":"2025-06-17","type":"trial","source":"GlobeNewswire","summary":"Oligonucleotides Clinical Trial Pipeline Analysis - GlobeNewswire","headline":"Oligonucleotides Clinical Trial Pipeline Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQcGQwVlRvTkVwUFJRSGhXV09Ib01pVS1mTm9rdUo5Y09FUC0zTjV6aHMtQ3ZKWXZxQldtRXVXUjIyVWRIZnhidDMxTkRUUGstZVdvV3FlcUx1ZnpJdXQ4LVVlc2p0WEJLM0JWQVE2anNhVmtiVXcwbmxkM19URGNvbExpQ3FLRjkzYXFqblZRZHlMT0pkYkZKREktNTU0Vi1o?oc=5","date":"2024-07-08","type":"pipeline","source":"BioSpace","summary":"Drug Developers Tap the Immune System to Supercharge ADCs - BioSpace","headline":"Drug Developers Tap the Immune System to Supercharge ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPMFhKNVo2TXR2Q3hTTHpEdHRPY3ppR1I1dERIdl9HaUJNN1BLN1FTdk0wYzFuanhaMFZqUUdaM1ppaFBUbGhCNTY1Y3ZQMFlwaXdMUW54NTI3MFNLcFBzRGNtSFV1RmRYbFN1cGVPdEpGUlRENkR5QWMtNzdJZXVEUkZHZEJIQnpvNVp3amVxLVhQQzJvejYtUkVBd1VzbEUyc2FDZFhLS1hwNVpVb0hHSDAxZVA1Tm43RFVXUmc0ME5mZDdSaE14Q1BSMzJ2a0JMdkNRTHE3ZHNQYjRuNVdaYm9UQ3ZkV0NRQU5YS1N3MWNmQ2toVGxwLWhMdkliVnRZbTBLbUhQOTJYR09QMUh2R3I4dVhkUmJJTmc?oc=5","date":"2023-09-27","type":"pipeline","source":"businesswire.com","summary":"Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting - businesswire.com","headline":"Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPbmFfN0lITjcxSlN1NXhfV0l6QzBNNHE1OHRMUjVDbzQtNjMweC1rc3J5NjNyc1Q3ZzF3Q2hZckRVYlpsQWliZTBPTjRQelpvaDBCdjRyUHE3aXFUQS12cGI4ZUczT3paRjZLQXpseUJVRW1FR0k0RnNHek9BN3lkbUtyWnBYWEF4SWR1TmVZWkYzR2xYNU9laW96YkJzS1BkcDBMQnZsY2ZqT3RVNjJUYXJDaUhKdm9NbWt0MmdUVGF1NE5CeXF4OGZ6WQ?oc=5","date":"2023-06-05","type":"pipeline","source":"Healio","summary":"Trastuzumab deruxtecan shows ‘broad activity’ in HER2-expressing solid tumors - Healio","headline":"Trastuzumab deruxtecan shows ‘broad activity’ in HER2-expressing solid tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZGtabnJNT3ZvTjZualJtWmlkLUw2R2tDTzJ6eC1wVG4xYldOQThYZEZ4UnBhcUl6MngtSG50SE5GZm1BbEJrMGhYWmEyeWx3bWtRdGN5cGYtcjh6N3Y1VVhFV2s0dlRVZ2RlbnBmVDRmREVyUGduZzNYc1NPaUgzWHRJVC1sbFVQOUFDNWVBWmJZTlJZckx5Tk1ZMmIyMTFFMGFTZzI4S2pNWFIxWnUxN1NsQ2pqb1k4cnk4RFQ4dnlBZw?oc=5","date":"2023-01-20","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—David Kessler resigns from the Biden admin, marking the unofficial end of Operation Warp Speed - Fierce Biotech","headline":"Chutes & Ladders—David Kessler resigns from the Biden admin, marking the unofficial end of Operation Warp Speed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQVEVsdmJXNWlxV2xFcEdTX3lZN2x2VWp0WVVMR1V4LXFHaDRrNWFVNkNkM1k5eUxVWnJzQ0Y5akt2bDBRd0FWTmUxTHpXRHlVYjV1bEdMMFJmbkhfNmxra19iVzRPUEhJR0U4V0NwLVlIYVlYLWRzZGRhSkMtN3M0bUZUWTBkTkN3X3ptRFJ3QmNERE5lVlFVUWxRSGpONGVHUU4xY3JQRk1ZU2NmZVJpV0M2RXRKbnBGT292Q3k1UE1hRzBhM1R5c2d1cw?oc=5","date":"2023-01-19","type":"pipeline","source":"businesswire.com","summary":"Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer - businesswire.com","headline":"Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPQUhvTFNXQjhGamg0a0ljQzc2UEtLU1hYTUMxb2ZrdVVWbU4yMDQ5MUVVeHZ1TVc3aVMxV0FrSE5vRUZIbE5EdWlyODdrcHF5YlZzcloyQ0pMM0xlVU1lR3c5Sm02ekswQ2kwb19HTnRGVHdJZ1pOV2RuOTN1ZnNGYnlsdTU2YVZfRHFwd2RVOWVuNzJ4MG12OER3M09waEVmT1ROMUl3RDNaZHFrZDRKMTZaZXhNVkwzZnZaVGxkTkpOQVFKT09GRkZoaFN1d2xnME1mNGhWdlIzejBxTmNvWDlteHRsWlVz?oc=5","date":"2022-02-21","type":"pipeline","source":"GlobeNewswire","summary":"Toll-Like Receptor Agonist Pipeline Insights | Research Report 2022 by DelveInsight - GlobeNewswire","headline":"Toll-Like Receptor Agonist Pipeline Insights | Research Report 2022 by DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOZkF2VzQyR08xLXBxc3JRVWJrME5MVlZOZ1c4N0FKUzVZOGVvaGtTYm80d1pPODNsQllYUC1DVEZuQ2ZLR1VYUHlhNlpKMU9HRU1fdzNtRW9mQXpLVjk2bm1sakVvT0RzTUNzVlhYS0lPWEZuQzFrUE1EYlBSbWotV2Z5ZGFwblVldmtJQjJnZG9EakozU0x3eEg0czlsc2ZfOVRhaGM0X1paQkt6YTl5ZkNaR0x0MjJqQWJoZHgwdzJ5dU5yd0hGcm9xVDd1MDhWdXgtTS1zOWpwOGN6WW9rYVhfVWxYYU53X3VYblJSVi1uN1dhTWhQMw?oc=5","date":"2021-03-23","type":"pipeline","source":"businesswire.com","summary":"Selexis and Tallac Therapeutics Collaborate to Advance Tallac’s Pipeline of Novel Immunotherapies in Oncology - businesswire.com","headline":"Selexis and Tallac Therapeutics Collaborate to Advance Tallac’s Pipeline of Novel Immunotherapies in Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNc3FWZENFRDNnMkJVUU9UemlYZ3NlWVJIbF9tVDhtNWtUZHRQRG1rcDZYZ29nMHVvbWt5T3QyQWhWd0YycHV3dGV5c01RUi1lS1FwSGJpbnZZblhvamsyb1ZZbFZYM2V5bHd4QnE2dkpiTVg1UkxZY05zNzFXVGpBSDlnQ3Z5UHJjXzBwSFVXVWtMcHFzODBCNGIzenNPU0ZOb2V5N2tIZVpYVGVnNm1VVm9ZUmpCZw?oc=5","date":"2020-12-01","type":"pipeline","source":"Fierce Biotech","summary":"Tallac Therapeutics launches with $62M run by ALX Oncology vets, with an eye on next-gen cancer - Fierce Biotech","headline":"Tallac Therapeutics launches with $62M run by ALX Oncology vets, with an eye on next-gen cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}